Adjuvant Treatment for Early Stage Hormone Positive Breast Cancer: Role of Genomic Signatures

Never miss sessions on the most clinically relevant abstracts and thought-provoking data in oncology. Subscribe to our channel!
From our 2021 University of Kansas Cancer Center Post San Antonio Review Conference, we bring you a session on Adjuvant Treatment for Early Stage Hormone Positive Breast Cancer: Role of Genomic Signatures by Dr. Ingrid Mayer.
To obtain CME/CE credits you must participate in the full University of Kansas Post San Antonio Review conference, click here to view all sessions: bit.ly/2OesV6d
Information on obtaining CME/CE Credits can be found in the playlist description.